ÂÜÀòÂÒÂ×

Matthew Fujisawa serves as the CFO at XO Health Inc. since February 2024, providing financial and strategic leadership for an early-stage HealthTech company. Previously, Matthew held the position of SVP, Strategy & Corporate Development at BenevolentAI from January to December 2023, directing corporate strategy and fostering new partnerships in the field of AI-enabled drug discovery. As the VP, Global Head of Corporate Development at Kry from September 2021 to January 2023, Matthew led global corporate development efforts, including M&A and strategic alliances. Prior experience includes roles at McKinsey & Company and co-founding Herald Health as CFO. Matthew also contributed to business development at Northwell Health, overseeing strategic initiatives and relevant acquisitions. Matthew earned an MBA with High Distinction from Harvard Business School and a B.A. from Dartmouth College.